Nogo-B mediates HeLa cell adhesion and motility through binding of Fibulin-5

Biochemical and Biophysical Research Communications

Volumn 398, Issue 2, 2010, Pages 247-253

  Zhou, Shumin ^a   Xiao, Wei ^a   Wan, Qingwen ^a   Yi, Changhua ^a   Xiao, Feifei ^a   Liu, Yingle ^a   Qi, Yipeng ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Cell motility; Fibulin 5; Nogo B; Secretion; Tumor metastasis

Indexed keywords

FIBULIN 5; PROTEIN NOGO; PROTEIN NOGO B; UNCLASSIFIED DRUG;

ARTICLE; CELL ADHESION; CELL INVASION; CELL MATURATION; CELL MEMBRANE; CELL MIGRATION; CELL MOTILITY; CYTOPLASM; ENZYME LINKED IMMUNOSORBENT ASSAY; HELA CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RNA INTERFERENCE; TUMOR CELL;

CELL ADHESION; CELL NUCLEUS; CYTOPLASM; ENDOPLASMIC RETICULUM; EXTRACELLULAR MATRIX PROTEINS; HELA CELLS; HUMANS; MYELIN PROTEINS; PROTEIN TRANSPORT;

EID: 77955058436     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.06.068     Document Type: Article

References (18)

1. Oertle T., Merkler D., Schwab M.E. Do cancer cells die because of Nogo-B?. Oncogene 2003, 22:1390-1399.
2. Su Z., Cao L., Zhu Y., Liu X., Huang Z., Huang A., He C. Nogo enhances the adhesion of olfactory ensheathing cells and inhibits their migration. J. Cell Sci. 2007, 120:1877-1887.
3. Liao H., Duka T., Teng F.Y., Sun L., Bu W.Y., Ahmed S., Tang B.L., Xiao Z.C. Nogo-66 and myelin-associated glycoprotein (MAG) inhibit the adhesion and migration of Nogo-66 receptor expressing human glioma cells. J. Neurochem. 2004, 90:1156-1162.
4. Miao R.Q., Gao Y., Harrison K.D., Prendergast J., Acevedo L.M., Yu J., Hu F., Strittmatter S.M., Sessa W.C. Identification of a receptor necessary for Nogo-B stimulated chemotaxis and morphogenesis of endothelial cells. Proc. Natl. Acad. Sci. USA 2006, 103:10997-11002.
5. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
6. Timpl R., Sasaki T., Kostka G., Chu M.L. Fibulins: a versatile family of extracellular matrix proteins. Nat. Rev. Mol. Cell Biol. 2003, 4:479-489.
7. Nonaka R., Onoue S., Wachi H., Sato F., Urban Z., Starcher B.C., Seyama Y. DANCE/fibulin-5 promotes elastic fiber formation in a tropoelastin isoform-dependent manner. Clin. Biochem. 2009, 42:713-721.
8. Yanagisawa H., Davis E.C., Starcher B.C., Ouchi T., Yanagisawa M., Richardson J.A., Olson E.N. Fibulin-5 is an elastin-binding protein essential for elastic fibre development in vivo. Nature 2002, 415:168-171.
9. Kowal R.C., Richardson J.A., Miano J.M., Olson E.N. EVEC, a novel epidermal growth factor-like repeat-containing protein upregulated in embryonic and diseased adult vasculature. Circ. Res. 1999, 84:1166-1176.
10. Katsuta Y., Ogura Y., Iriyama S., Goetinck P.F., Klement J.F., Uitto J., Amano S. Fibulin-5 accelerates elastic fibre assembly in human skin fibroblasts. Exp. Dermatol. 2008, 17:837-842.
11. Gallagher W.M., Currid C.A., Whelan L.C. Fibulins and cancer: friend or foe?. Trends Mol. Med. 2005, 11:336-340.
12. Albig A.R., Schiemann W.P. Fibulin-5 function during tumorigenesis. Future Oncol. 2005, 1:23-35.
13. Freeman L.J., Lomas A., Hodson N., Sherratt M.J., Mellody K.T., Weiss A.S., Shuttleworth A., Kielty C.M. Fibulin-5 interacts with fibrillin-1 molecules and microfibrils. Biochem. J. 2005, 388:1-5.
14. Preis M., Cohen T., Sarnatzki Y., Ben Yosef Y., Schneiderman J., Gluzman Z., Koren B., Lewis B.S., Shaul Y., Flugelman M.Y. Effects of fibulin-5 on attachment Adhesion, and proliferation of primary human endothelial cells. Biochem. Biophys. Res. Commun. 2006, 348:1024-1033.
15. Dodd D.A., Niederoest B., Bloechlinger S., Dupuis L., Loeffler J.P., Schwab M.E. Nogo-A -B, and -C are found on the cell surface and interact together in many different cell types. J. Biol. Chem. 2005, 280:12494-12502.
16. Acevedo L., Yu J., Erdjument-Bromage H., Miao R.Q., Kim J.E., Fulton D., Tempst P., Strittmatter S.M., Sessa W.C. A new role for Nogo as a regulator of vascular remodeling. Nat. Med. 2004, 10:382-388.
17. Argraves W.S., Greene L.M., Cooley M.A., Gallagher W.M. Fibulins: physiological and disease perspectives. EMBO Rep. 2003, 4:1127-1131.
18. Albig A.R., Neil J.R., Schiemann W.P. Fibulins 3 and 5 antagonize tumor angiogenesis in vivo. Cancer Res. 2006, 66:2621-2629.